Skip to content
Medical Health Aged Care

Centenary Institute and Cure the Future join forces to tackle rare diseases

Centenary Institute 3 mins read

The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.

 

The collaboration will see the Foundation support the development of advanced gene and cell therapies at the Centenary Institute, uniting scientific expertise with a shared commitment to improving human health.

 

Funds raised by Cure The Future will support pioneering research led by Dr Charles (Chuck) Bailey and his team at the Centenary Institute’s Centre for Rare Diseases & Gene Therapy. Their work is focused on using advanced molecular therapies to treat a range of serious rare diseases. These include severe genetic disorders such as Pompe disease and Duchenne muscular dystrophy, autoimmune diseases and rare cancers like mesothelioma.

 

“Gene therapy has the potential to transform medicine by addressing disease at its source,” said Dr Bailey. “By repairing or modifying genes within cells, we’re developing more precise and effective treatments that go beyond symptom management.”

 

“Ultimately, our goal is to deliver lasting cures by targeting the underlying causes of disease,” he said.

 

Professor Marc Pellegrini, Executive Director of the Centenary Institute, said the partnership is a powerful alignment of research and philanthropy.

 

“This collaboration brings together cutting-edge science with a shared mission to tackle some of the most challenging rare genetic diseases and cancers,” Professor Pellegrini said.

 

“With the support of the Cure The Future Foundation, we can advance discoveries that have the potential to redefine what’s possible in genetic medicine and transform lives for the better.”

 

He added, “We’re incredibly grateful to the Foundation for their belief in our work and their commitment to making a meaningful difference in the lives of patients affected by serious disease.”

 

Diane Langmack OAM, Board Chair of Cure The Future Foundation, said she was proud to be partnering with the Centenary Institute to advance urgently needed research.

 

“This partnership is a really special moment for us. Working with the Centenary Institute means we’re helping push forward the kind of research that changes lives. It brings real hope to families facing serious illness and helps fast-track the discoveries that can make all the difference,” she said.

 

“At Cure The Future Foundation, we’re proud to back brilliant minds driving life-changing research. This partnership shows the incredible impact we can have when people unite with purpose, because the true strength of humanity lies in working together.”

 

The partnership has just been officially launched, reinforcing both organisations' shared commitment to advancing world-leading medical research that delivers both hope and better health outcomes for people affected by rare diseases.

 


About us:

About the Centenary Institute

The Centenary Institute is a world-leading independent medical research institute, closely affiliated to the University of Sydney and the Royal Prince Alfred Hospital. Our research spans the critical areas of cancer, cardiovascular disease, rare diseases, inflammation, infectious diseases, healthy ageing and biomedical AI. Our strength lies in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients. For more information about the Centenary Institute, visit centenary.org.au

 About Cure The Future Foundation

Cure The Future Foundation funds world-leading scientists who are transforming once-untreatable conditions into real, proven treatments and cures – saving lives today and unlocking hope for future generations. Every donation supports urgent research, life-changing breakthroughs, and brighter futures for families who deserve more time and more answers. At Cure The Future Foundation, we don’t just fund science. We fund life. For more information about Cure The Future Foundation, visit https://curethefuture.org/


Contact details:

For all media and interview enquiries, please contact

Tony Crawshaw, Media and Communications Manager, Centenary Institute on 0402 770 403 or email: [email protected]

Ramy Haidar, Media Contact, Cure The Future Foundation on 0425 410 676 or email: [email protected]

More from this category

  • Medical Health Aged Care
  • 12/02/2026
  • 14:44
Royal Australian College of GPs

GPs call for stronger action on racism to close the gap in Australia

In response to the Federal Government’s latest Closing the Gap report,the RACGP welcomes the investments announced by the Government and calls on all Australian governments to put more resources into tackling racism in 2026 to ensure that it is a not a barrier to Aboriginal and Torres Strait Islander communities achieving their aspirations. The call comesfollowing the release ofaLowitja Institute reporthighlighting the effects of racism on the health of Aboriginal and Torres Strait Islanderchildren. RACGP President Dr Michael Wright said: “We congratulate the Government on recognising the inspiration and aspiration of Aboriginal and Torres Strait Islander peoples and acknowledging that…

  • Medical Health Aged Care
  • 12/02/2026
  • 14:38
Australian Society of Anaesthetists

ASA Welcomes Improved Transparency for Private Health Members

The Bill aims to strengthen transparency and improve patients’ understanding of their healthcare and private health insurance arrangements. The ASA supports these objectives and…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 12/02/2026
  • 09:37
I-screen - an Australian-founded health technology company

Former AWS and Accenture AI Leader Joins Australian Healthtech i-screen as AI Push Accelerates

Key points High-profile global AI executive appointment signals next growth phase for Australian healthtech Brad Ryan appointed Chief AI Officer – Former AWS APJ Data & AI Partner Lead and Accenture Managing Director with 30+ years technology leadership experience Platform scale now approaching 1 million diagnostic tests across four countries Singapore expansion positions i-screen as a regional AI-driven preventive health player AI investment focused on earlier detection, personalised screening and longevity insights Australian-founded health technology company i-screen has appointed senior global technology executive Brad Ryan,GAICD, as Chief AI Officer, strengthening its leadership team as the business deepens its investment in…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.